Ginsenoside Rg1

CAS: 22427-39-0

Ref. TR-G387485

Produktinformation

• Name: Ginsenoside Rg1
• Synonyme: Panaxoside A, Dammarane, β-D-glucopyranoside deriv., Ginsenoside A2, Ginsenoside g1, Panaxoside Rg1, Panaxsaponin Rg1, Sanchinoside C1, Sanchinoside Rg1, (3β,6α,12β)-3,12-Dihydroxydammar-24-en-6,20-diylbis[β-D-glucopyranosid], (3β,6α,12β)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-β-<span class="text-smallcaps">D</span>-glucopyranoside, (3β,6α,12β)-3,12-dihidroxidamar-24-eno-6,20-diilbis[β-D-glucopiranosido], (3β,6α,12β)-3,12-dihydroxydammar-24-ene-6,20-diylbis[β-D-glucopyrannoside], (3β,6α,12β)-3,12-dihydroxydammar-24-ene-6,20-diylbis[β-D-glucopyranoside], Dammarane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv., Ginsenoside A₂, Ginsenoside Rg₁, Ginsenoside g₁, Panaxoside Rg₁, Rg1 ginsenoside, Rg₁ ginsenoside, Sanchinoside C₁, Sanchinoside Rg₁, β-<span class="text-smallcaps">D</span>-Glucopyranoside, (3β,6α,12β)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-

Beschreibung

Stability Hygroscopic
Applications Ginsenoside Rg1 protects against arthitis through osteoclast differentiation inhibition. Anti-tumor agent, inhibits the NF-kB-dependant MMP-expression in PMA (phorbol myristate acetate)-induced tumor cell invasion.
References Gu, Y. et al.: Med. Infl., 305071/14. (2014); Li, L. et al. Onc. Rep., 32, 1779 (2014);

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 801.01
• Formel: C₄₂H₇₂O₁₄
• Farbe/Form: Neat
• InChl: InChI=1S/C42H72O14/c1-20(2)10-9-13-42(8,56-37-34(52)32(50)30(48)25(19-44)55-37)21-11-15-40(6)28(21)22(45)16-26-39(5)14-12-27(46)38(3,4)35(39)23(17-41(26,40)7)53-36-33(51)31(49)29(47)24(18-43)54-36/h10,21-37,43-52H,9,11-19H2,1-8H3/t21-,22+,23-,24+,25+,26+,27-,28-,29+,30+,31-,32-,33+,34+,35-,36+,37-,39+,40+,41+,42-/m0/s1
• InChI Key: InChIKey=YURJSTAIMNSZAE-HHNZYBFYSA-N
• SMILES: CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C